Minims Oxybuprocainhydrochlorid Bausch + Lomb Ireland Limited (Oxybuprocaine Hydrochloride)

Oxybuprocaine Hydrochloride, the active ingredient in Minims Oxybuprocainhydrochlorid, is an ester‑type local anesthetic presented as a sterile ophthalmic solution for topical ocular use. It produces reversible surface anesthesia of the cornea and conjunctiva, facilitating diagnostic examinations and minor therapeutic procedures on the eye.

GNH USA supplies Minims Oxybuprocainhydrochlorid as a licensed, GDP‑compliant international pharmaceutical product, providing the formulation to hospitals, pharmacies and clinics worldwide under EU‑market standards. The company ensures quality control, regulatory compliance and reliable logistics where required.

Oxybuprocaine Hydrochloride is used as a topical ocular anesthetic to temporarily block sensation in the eye.

Diagnostic ocular examinations: provides surface anesthesia to allow slit‑lamp or fundus evaluation without discomfort. Minor ocular surgical procedures: facilitates anesthesia for foreign body removal, laser treatment, or minor incisions. Therapeutic eye interventions: prepares the eye for drug administration or minor therapeutic manipulations.

Oxybuprocaine Hydrochloride may cause local ocular reactions and, rarely, systemic effects.

Common Side Effects: - Transient burning or stinging: mild discomfort upon instillation - Redness of the conjunctiva: temporary hyperemia - Tearing: increased lacrimation - Blurred vision: short‑term visual disturbance - Foreign body sensation: feeling of grit - Mild allergic conjunctivitis: limited itching

Serious or Rare Side Effects: - Corneal epithelial toxicity: rare ulceration or delayed healing - Severe allergic reaction: anaphylaxis or angioedema - Systemic toxicity: CNS depression or cardiac arrhythmia (extremely rare) - Persistent numbness: prolonged loss of sensation beyond expected duration

When using Minims Oxybuprocainhydrochlorid, consider the following precautions. - Allergy assessment: avoid use in patients with known hypersensitivity to oxybuprocaine or ester anesthetics - Contact lens wearers: remove lenses before administration to prevent drug retention - Pre‑existing corneal disease: use with caution in keratitis or epithelial defects - Pediatric use: limit to recommended indications and monitor closely - Repeated dosing: avoid frequent applications to reduce risk of toxicity - Store at room temperature: keep container tightly closed, protect from light and moisture

Oxybuprocaine Hydrochloride can interact with other medications; awareness of potential interactions is important.

Major Interactions (Avoid): - Systemic anesthetics: concurrent use may potentiate CNS depression - Beta‑blocker eye drops: may increase ocular hypotension - Other topical ocular anesthetics: additive local toxicity - Anticholinergic eye drops: may exacerbate dry eye - MAO inhibitors: theoretical risk of increased systemic effects

Moderate Interactions (Monitor Closely): - Antihistamine eye drops: may alter drug absorption - Topical antibiotics: monitor for delayed wound healing - Non‑steroidal anti‑inflammatory eye drops: watch for corneal toxicity